• Medical_Professionals
• Medical_students
• Nurses

With continued growth and evolving market dynamics, sales of global biosimilars is forecasted to reach $25 billion in the year of 2020 and Asia is expected to ride on the uphill trend. Biosimilar regulations are expected to change and having the right commercialization strategy will be the key to accessing new markets.

At IBC’s Biosimilars Asia Conference, top industry players will explore practical strategies for gaining access to emerging markets, clarifying regulatory pathways and clinical approvals, evaluating business models, risks and investment opportunities, pricing and commercialization strategies and successful case studies.

Why you should attend

Gain in-depth content from leading biosimilars companies and case studies on market access and commercialization strategies

Understand the latest development in regulations and Government pricing plans in China, EU, US, Korea and India, how to access these markets and gain approvals

Insights on key success factors for entering the biosimilars investment space with different business models as well as developing win-win partnerships  

Learn innovative and cost effective approaches in biosimilars production and development

Gather the latest market intelligence and analysis and identify new trends and opportunities in Biosimilars R&D, contract manufacturing and commercialization in Asia

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Event Planning Team

Grand Hyatt Shanghai

上海金茂君悦大酒店 

Jin Mao Tower, 88 Century Avenue Pudong, Shanghai 200121, China

上海市浦东世纪大道88号金茂大厦 邮政编码：200121 

+86 21 5047 1234 Ext. 8780 TELEPHONE电话 

+86 21 5049 8381 FAX传真 

+86 183 2100 9773 MOBILE 手机 

cherry.chen-shagh@hyatt.com 

shanghai.grand.hyatt.com

Submission Info

Merck Millipore is the Life Science division of Merck KGaA and offers a broad range of products used by pharmaceutical and biotechnology companies to develop and manufacture biopharmaceutical drugs safely and efficiently. We provide fully integrated solutions to biopharmaceutical customers and an attractive range of products and regulatory services for the entire value chain for the production of small-molecule-based pharmaceuticals and upstream production of large-molecule-based biopharmaceuticals

BRONZE SPONSORS

BD is a leading medical technology company that partners with customers and stakeholders to address many of the world’s most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of “Helping all people live healthy lives” by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit www.bd.com.

Customer Service & Bookings Hotlines

Email register@ibcasia.com.sg

Email +65 6508 2401

Email +86 21 2326 3680 (China)

Email +65 6508 2407